別品名 |
Octanoic Acid (3S,3aR,4S,6S,6aR,7S,8S,9bS)-6-(Acetyloxy)-2,3,3a,4,5,6,6a,7,8,9b- decahydro-3,3a-dihydroxy-3,6,9-trimethyl-8-[[(2Z)-2-methyl-1-oxo-2-butenyl]oxy]-2-oxo-4-(1-oxobutoxy)azuleno[4,5-b]furan-7-yl Ester; (-)-Thapsigargin; Octanoic Acid [3S-[3α,3aβ,4α,6β,6aβ,7β,8α(Z),9bα]]-6-(Acetyloxy)-2,3,3a,4,5,6,6a,7,8,9b-decahydro-3,3a-dihydroxy-3,6,9-trimethyl-8-[(2-methyl-1-oxo-2-butenyl)oxy]-2-oxo-4-(1-oxobutoxy)azuleno[4,5-b]furan-7-yl Ester;
|
分子量 |
650.75
|
CAS RN® |
67526-95-8
|
構造 |
C34H50O12
|
溶媒 |
Chloroform (Slightly), Methanol (Slightly, Heated)
|
使用目的 |
A widely used inhibitor of the ubiquitous sarco-endoplasmic reticulum Ca(2+)-ATPases in mammalian cells. It acts as a potent, cell-permeable, IP3-independent intracellular calcium releaser that blocks the transient increase in intracellular Ca2+ induced by angiostatin and endostatin. It induces apoptosis by disrupting intracellular free Ca2+ levels.
|
その他 |
[性状]White to Pale Brown Solid
|
参考文献 |
Treiman, M. et al.: Trends Pharmacol. Sci., 19, 131 (1998); Korge, P. et al.: Eur. J. Biochem., 265, 273 (1999); Tsukamoto, A. Cell Biol. Int., 17, 969 (1993); Kutinova C.N. et al.: Cell Biol. Toxicol., 23, 337 (2007);
|
※サムネイル画像をクリックすると拡大画像が表示されます。
|
|
|
メーカー |
品番 |
包装 |
TRC
|
T339250
|
5 MG
|
※表示価格について
当社在庫 |
なし
|
納期目安 |
2週間程度
|
保存温度 |
-20℃
|
|